Cite
HARVARD Citation
Tyryshkin, K. et al. (2023). Expression of TCF3 target genes defines a subclass of diffuse large B-cell lymphoma characterized by up-regulation of MYC target genes and poor clinical outcome following R-CHOP therapy. Leukemia & lymphoma. 64 (1), pp. 119-129. [Online].